The prognostic role of baseline CEA and CA 19-9 values and their time-dependent variations in advanced colorectal cancer patients submitted to first-line therapy

Tumor markers CEA and CA 19-9 correlate with radiological imaging in metastatic colorectal cancer patients receiving first-line chemotherapy

(2014) M. Michl et al.   TUMOR BIOLOGY

CA 19-9: handle with care

(2013) Claudio Galli et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review

(2012) X. Liao et al.   CLINICAL CANCER RESEARCH

Prognostic and predictive biomarkers for epidermal growth factor receptor-targeted therapy in colorectal cancer: Beyond KRAS mutations

(2012) Ana Custodio et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer

(2012) Paul Lochhead et al.   EUROPEAN JOURNAL OF CANCER

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Application of a Time-Varying Covariate Model to the Analysis of CA 19-9 as Serum Biomarker in Patients with Advanced Pancreatic Cancer

(2010) S. Boeck et al.   CLINICAL CANCER RESEARCH

Systematic Review of Prognostic Factors Related to Overall Survival in Patients with Stage IV Colorectal Cancer and Unresectable Metastases

(2010) Andrew P. Stillwell et al.   WORLD JOURNAL OF SURGERY

The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy

(2009) A. S. Strimpakos et al.   ANNALS OF ONCOLOGY

In chronic viral hepatitis without malignancy, abnormal serum carbohydrate 19-9 antigen levels are associated with liver disease severity and are related to different viral aetiology

(2009) Gaetano Bertino et al.   DIGESTIVE AND LIVER DISEASE